Biolife Solutions (BLFS) Non Operating Investment Income (2014 - 2024)
Biolife Solutions (BLFS) posted quarterly Non Operating Investment Income of -$4.1 million for Q2 2024, down 891.24% quarter-over-quarter from -$411000.0 in Q1 2023.
Biolife Solutions (BLFS) Non Operating Investment Income (2014 - 2024) Analysis & Trends
Biolife Solutions (BLFS) has reported Non Operating Investment Income for 6 consecutive years, with -$4.1 million the latest figure, recorded in Q2 2024.
- In Q2 2024, Non Operating Investment Income changed N/A year-over-year to -$4.1 million; the TTM figure through Jun 2025 stood at -$4.1 million (changed 0.0% YoY), while the FY2024 annual figure was -$4.1 million, changed N/A from the prior year.
- Non Operating Investment Income eased to -$4.1 million in Q2 2024 per BLFS's latest filing, from -$411000.0 in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $1.1 million in Q3 2020 and bottomed at -$4.1 million in Q2 2024.
- Historically, Non Operating Investment Income has averaged -$442166.7 across 4 years, with a median of $12500.0 in 2020.
- On a YoY basis, Non Operating Investment Income climbed as much as 123.37% in 2023 and fell as far as 123.37% in 2023.
- Biolife Solutions' Non Operating Investment Income stood at $209000.0 in 2020, then surged by 233.49% to $697000.0 in 2022, then slumped by 158.97% to -$411000.0 in 2023, then sank by 891.24% to -$4.1 million in 2024.
- Business Quant data shows BLFS's Non Operating Investment Income at -$4.1 million in Q2 2024, -$411000.0 in Q1 2023, and $697000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 1.00 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Biolife Solutions | 1.82 Bn | 1.73 Bn | 18.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -4.07 Mn |
| Jun 30, 2024 | -4.07 Mn |
| Mar 31, 2023 | -411,000.00 |
| Mar 31, 2023 | -411,000.00 |
| Sep 30, 2022 | 697,000.00 |
| Sep 30, 2022 | 697,000.00 |
| Mar 31, 2022 | -184,000.00 |
| Mar 31, 2022 | -184,000.00 |
| Dec 31, 2020 | 209,000.00 |
| Dec 31, 2020 | 209,000.00 |
| Sep 30, 2020 | 1.11 Mn |
| Sep 30, 2020 | 1.11 Mn |
| Jun 30, 2015 | -441.00 |
| Jun 30, 2015 | -441.00 |
| Dec 31, 2014 | 158.00 |
| Dec 31, 2014 | 158.00 |
| Sep 30, 2014 | -3,099.00 |
| Sep 30, 2014 | -3,099.00 |
| Jun 30, 2014 | -3,507.00 |
| Jun 30, 2014 | -3,507.00 |